| DaVita Inc. (DVA) Given New $100.00 Price Target by UBS AG (UBS) Analysts. - NewsyStocks.com |
|
|
NewsyStocks.com DaVita Inc. (DaVita) is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2009, the Company operated or provided administrative |